Gilde Healthcare reaches final close on GHC III
Gilde Healthcare has reached a final close of its 145 million euros ($200 million) transatlantic growth capital fund, Gilde Healthcare III. The new fund targets investment in innovative businesses in home and digital health, medical devices, diagnostics and therapeutics in the United States and in Europe.
26 November 2013•2 mins read
